Trials / Completed
CompletedNCT00076973
An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
A Randomized, 2-Period, Multicenter, Dble-Blind, Parallel-Group Study Comparing Effects of 2 Doses of MK0476 and Placebo in the Tx of Respiratory Symptoms Associated w/ Respiratory Syncytial Virus-Induced Bronchiolitis in Children 3 to 24 Mths
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,125 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 3 Months – 24 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | Duration of Treatment: 6 months |
| DRUG | Comparator: placebo | Duration of Treatment: 6 months |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2006-06-01
- Completion
- 2006-10-01
- First posted
- 2004-02-16
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00076973. Inclusion in this directory is not an endorsement.